KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Depreciation & Amortization (CF) (2017 - 2025)

Historic Depreciation & Amortization (CF) for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to $267383.0.

  • Co-Diagnostics' Depreciation & Amortization (CF) fell 2387.35% to $267383.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 1025.16%. This contributed to the annual value of $1.4 million for FY2024, which is 1192.97% up from last year.
  • Latest data reveals that Co-Diagnostics reported Depreciation & Amortization (CF) of $267383.0 as of Q3 2025, which was down 2387.35% from $291414.0 recorded in Q2 2025.
  • Co-Diagnostics' Depreciation & Amortization (CF)'s 5-year high stood at $424342.0 during Q2 2022, with a 5-year trough of $67005.0 in Q1 2021.
  • Over the past 5 years, Co-Diagnostics' median Depreciation & Amortization (CF) value was $298618.0 (recorded in 2022), while the average stood at $266582.3.
  • In the last 5 years, Co-Diagnostics' Depreciation & Amortization (CF) skyrocketed by 49171.43% in 2022 and then plummeted by 2806.6% in 2023.
  • Over the past 5 years, Co-Diagnostics' Depreciation & Amortization (CF) (Quarter) stood at $102606.0 in 2021, then surged by 191.03% to $298618.0 in 2022, then increased by 4.78% to $312878.0 in 2023, then increased by 14.14% to $357123.0 in 2024, then dropped by 25.13% to $267383.0 in 2025.
  • Its Depreciation & Amortization (CF) was $267383.0 in Q3 2025, compared to $291414.0 in Q2 2025 and $280445.0 in Q1 2025.